Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Corcept Therapeutics Inc.

Report MOMENTUM trial results

Delivered after the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
5 May 2025
Due
31 Dec 2025
Delivered
March 2026
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“Results expected by year-end”

What we found

Evidence strength A What the grades mean

The company committed to reporting MOMENTUM trial results by year-end 2025, but the results were not presented until the American College of Cardiology meeting in March 2026.

  • A
    Corcept Therapeutics Inc. 8-K filed 2026-02-24 Regulatory filing · published 24 Feb 2026 · retrieved 1 Oct 2026 · kept permanently by the SEC · fingerprint eb9bfc4908d9
    “Results from MOMENTUM, our trial evaluating the prevalence of hypercortisolism in patients with resistant hypertension, will be featured in an oral presentation at the American College of Cardiology (ACC) meeting in March.” ✓ confirmed on the page
  • A
    Corcept Therapeutics Inc. 10-Q filed 2026-07-29 Regulatory filing · published 29 Jul 2026 · retrieved 1 Oct 2026 · kept permanently by the SEC · fingerprint 08ae4d0e526a
    “MOMENTUM’s results were presented at the American College of Cardiology Annual Scientific Session in March 2026.” ✓ confirmed on the page

Market reaction: the shares moved +0.2% against the S&P 500 over the three sessions around the disclosure (23 Feb 2026 to 26 Feb 2026). What this measures

Checked 1 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Report
Deliverable
MOMENTUM trial results
Language
Expected (“expects”, “plans”)
In the company’s control
High
Specificity
Medium

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Corcept Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2025-CORT-002913 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.